TP53 and colonic neoplasm: Having established the effectiveness in vitro for AMPK inhibitor-induced chemosensitization to topotecan in p53 wild-type human colon cancer cells, the xenograft model in nude mice was generated to explore whether AMPK inhibition was involved in chemosensitization to topotecan in vivo.